acetylgalactosamine has been researched along with B16 Melanoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, L; Jondal, M; Olofsson, S; Sundbäck, J | 1 |
| Antolíková, M; Bezouska, K; Bílý, J; Hofbauerová, K; Ivanová, L; Kavan, D; Kovalová, A; Kren, V; Kubícková, M; Kubínková, Z; Ledvina, M; Libigerová, M; Mrázek, H; Pompach, P; Rozbeský, D; Saman, D; Sklenár, V; Vanek, O; Zídek, L; Zyka, D | 1 |
2 other study(ies) available for acetylgalactosamine and B16 Melanoma
| Article | Year |
|---|---|
Interference with O-glycosylation in RMA lymphoma cells leads to a reduced in vivo growth of the tumor.
Topics: Acetylgalactosamine; Animals; Anti-Inflammatory Agents, Non-Steroidal; Benzyl Compounds; Cell Survival; Enzyme Inhibitors; Glucosylceramidase; Glycosylation; Humans; Indolizines; Killer Cells, Natural; Lymphoma; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Tumor Cells, Cultured | 2006 |
Synthetic N-acetyl-D-glucosamine based fully branched tetrasaccharide, a mimetic of the endogenous ligand for CD69, activates CD69+ killer lymphocytes upon dimerization via a hydrophilic flexible linker.
Topics: Acetylglucosamine; Animals; Antigens, CD; Antigens, Differentiation, T-Lymphocyte; Antineoplastic Agents; Carbohydrate Sequence; Cell Line, Tumor; Dimerization; Drug Screening Assays, Antitumor; Female; Humans; Immunologic Factors; In Vitro Techniques; Killer Cells, Natural; Lectins, C-Type; Ligands; Lymphocyte Activation; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Models, Molecular; Molecular Mimicry; Molecular Sequence Data; NK Cell Lectin-Like Receptor Subfamily B; Oligosaccharides; Rats; Recombinant Proteins | 2010 |